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Abstract
Aim: Rathke's cleft cysts and craniopharyngiomas tipically involve sellar region and their histogenetic relationship
is still matter of debate. Clinical and histopathologic differentiation of cystic lesions from the sellar region, that is,
craniopharyngiomas (CPs) and Rathke cleft cysts (RCCs), is challenging and has great importance with respect to
variable clinical manifestation and adapted surgical treatment strategies in both entities. The recent acquisition that
adamantinomatous and papillary craniopharyngiomas bear distinct molecular alterations i.e., β-catenin (CTNNB1)
and BRAFv600 mutations respectively, has suggest to screen for such alteration a series of Rathke cyst to seek a
possible relation with one of the two craniopharyngioma type.
Methods: Seven Rathke's cleft cysts were analyzed for BRAF and CTNNB1 mutational status by sequencing and
immunohistochemistry. Radiological, clinical and histological features were performed.
Results: None of the 7 Rathke's cleft cysts harbor BRAFV600E mutation. No CTNNB1 mutation was found.
Radiological, clinical and histological re-evaluation of the cases confirmed the diagnosis of Rathke's cleft cysts.
Conclusion: BRAFV600E and CTNNB1 mutations appeared, as most reliable factor for the differentiation
between purely cystic CPs and RCCs, whereas tumor location, tumor size, and radiological parameter of the tumor
were less consistent parameters. This study again confirms that craniopharyngiomas (CPs) and Rathke cleft cysts
(RCCs), are associated with distinct pathogenic pathways.
Keywords: BRAFV600E mutation; Rathke's cleft cysts;
Craniopharyngioma; Sequencing
Introduction
Rathke’s cleft cyst (RCC) and craniopharyngiomas (CP) involve the
cellar region and sometimes histological evaluation is challenging
especially when small tissue specimens are available for analysis. Both
lesions are considered to arise from the remnants of Rathke’s
diverticulum [1].
Some authors have suggested that these lesions are part of a disease
spectrum extending from RCC to craniopharyngioma [2]. Intracystic
hemorrhage or inflammation may induce metaplasia in the single
cuboidal epithelium of RCC to form stratified squamous epithelia
resulting in the induction of craniopharyngioma [3]. Besides the
presence of ciliated and goblet cell in some craniopharyngiomas are
believed to provide evidence for this [4,5]. Moreover most of the CPs
are larger than 20 mm, whereas most of RCCs are smaller than 20 mm
in diameter. However, these parameters are insufficient to rule out
small cystic CP variants, which do not exhibit any other difference in
computed tomography (CT), or magnetic resonance imaging (MRI)
[6].
Although CPs and RCCs are histologically benign, they exhibit a
different clinical behavior and thus require different surgical treatment
strategies. The rates of recurrence and progression, respectively and the
interval of progression-free survival in CPs is obviously depending on
the extent of surgical removal [7]. The recurrence rate is significantly
lower in patients with RCC even after subtotal or partial removal [7].
The outcome is much better and one might conclude from previous
data that radical excision is not necessary in these lesions. On the basis
of these data distinction between the lesions is truly important.
However, the small tissue specimens available for analysis and the
similar histological features cause a tricky interpretation.
Previous work has shown that mutations in CTNNB1 with nuclear
accumulation of β-catenin are a reliable marker for the identification
of craniopharyngiomas of the adamantinomatous subtype [5f].
Whereas papillary craniopharyngiomas are characterized by BRAF
V600E mutations as genetic hallmark and consistently don’t show
nuclear β-catenin expression [8].
On the basis of these data we investigated 7 Rathke's cleft cysts to
determine the presence of BRAF V600E and beta-catenin mutations
and its suitability as diagnostic marker for the differentiation of cystic
lesions of the cellar region. For each case clinical, radiological and
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histopathological parameters were also re-evaluated in order to exclude
features typical for craniopharyingoma.
Materials and Methods
Patient selection and immunohistochemistry
Surgical specimens from 7 patients with Rathke’s cleft cysts were
selected retrospectively on the basis of the availability of formalin-fixed
paraffin embedded material (FFPE) from two different institutions, the
Mediterranean Neurologic Institute (Neuromed), Pozzilli, Italy, and the
Pathology Service of University Sapienza, Rome, Italy.
All Rathke’s cleft cysts were reviewed by two neuropathologist MA
and FG and diagnosed according to the AFIP Atlas of Tumor
Pathology (Tumors of the Central Nervous System, Series 4 Fascicle 7).
Primary antibody against BRAF p.Val600Glu (clone VE1, 1:100,
Spring Bioscience, Pleasanton, CA): positive staining was characterized
by diffuse and moderate cytoplasmic staining of the tumor cells.
Primary antibody against β-catenin antigen (BD Pharmingen,
610154, mouse monoclonal, clone 14): were scored as positive, and
cases with membranous staining were scored as negative.
Isolation of DNA
DNA was extracted from FFPE tissue specimens with the QIAamp
DNA Mini Kit, as described by the manufacturer (Qiagen S.A.,
Courtaboeuf France), DNA concentration was quantified using the
Nanodrop ND-1000 UV-Vis spectrophotometer (Labtech France,
Palaiseau, France). Final products were stored at -20°C until use.
Moreover standard diagnostic procedures were performed. Sections
were stained with ematoxilin and eosin.
BRAFV600E and CTNNB1 mutation analysis
Mutational analysis was performed amplifying DNA with the
primers as follows: BRAF exon 15, 5'-
TCATAATGCTTGCTCTGATAGGA-3' (sense) and 5'-GGC
CAAAAATTTAATCAGTGGA-3' (antisense). The PCR products were
purified using the automated system Biomek NXp by Beckman Coulter
and Agentcourt AMPure XP reagents. Purified products were
submitted to PCR cycle sequencing conditions as follow: denaturation
at 95°C for 30 s, annealing at 50°C for 15 s, and extention at 60°C for
240 s. The cycle sequencing products were purified using the same
automated system and Agentcourt Clean SEQ reagents. Sequencing
analysis was performed using the ABI 3130 XL DNA analyser (Applied
Biosystem).
For β-catenin, a 630 base pair genomic PCR fragment spanning
codon 1 (exon 2) to codon 92 (exon 4) was amplied using primers
primers BCATEX2F (GAAAATCCAGCGTGGACAATG) and
BCATEX4R (TCGAGTCATTGCA- TACTGTCC).
Results
Clinical, histological and radiological findings
The series of 7 Rathke’s cleft cysts comprised 7 females and 1 male,
with a median age of 38. Cases were located within the sella turcica
except for one located in the sphenoidal bone (Table 1).
Case Age
(years)/
Sex
RCC histology BRAFV600
E mutation
ß-
catenin
mutatio
n
1 56 F Ciliated cuboidal and columnar
epithelium with squamous
metaplasia
No No
2* 16 F Ciliated cuboidal and columnar
epithelium
No No
3 55 F Ciliated cuboidal and columnar
epithelium
No No
4 33 F Ciliated cuboidal and columnar
epithelium
No No
5 48 F Ciliated cuboidal and columnar
epithelium with squamous
metaplasia
No No
6 29 F Ciliated cuboidal and columnar
epithelium
No No
7 32 M Ciliated cuboidal and columnar
epithelium
No No
Table 1: RCC histology and mutations in different cases.
We further added two cases of craniopharingiomas, one papillary
and one adamantinomatous, in which the histological and radiological
features were typical. The histological examination showed cuboidal or
columnar ciliated epithelium on a fibrous tissue. In three of 7 Rathke
cleft cysts (n.1 n.2 n.5) co-existence of squamous cell metaplasia and
cilia with scattered goblet cells could be identified. The intrasphenoidal
case (n.2) showed columnar cilated epithelium with few mucinous cells
(Figure 1).
Figure 1: Case 1 A) Haematoxylin and eosin staining show co-
existence of squamous cell metaplasia and cilia with scattered goblet
cells; B) BRAFV600E sequencing demonstrate the wild type gene.
Case 2 C) Haematoxylin and eosin staining show show cuboidal or
columnar ciliated epithelium on a fibrous tissue; D) BRAFV600E
sequencing demonstrate the wild type gene.
Radiological re-evaluation in all seven cases demonstrated the
typical MR finding of a Rathke’s cleft cyst such as dumbell-shaped cyst,
with hypointense signal in T1-weighted images, and hyperintense
signal in T2-weighted images, relative to normal brain parenchyma
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and they were smaller than 20 mm in diameter. Moreover in three of 7
Rathke cleft cysts (n.1 n.2 n.5) and the intrasphenoidal lesion (n.2)
MRI showed findings typical of a cystic lesion.
All reported cases achieve remission, except for a single patient that
developed repeated re-accumulation of the mucus and become
intractable (Figure 1).
BRAFV600E and β-catenin mutational status by
immunohistochemistry
Immunoistochemical for BRAFV600E protein was found negative
in all RCCs, as well the cases did not show nuclear expression for ß-
catenin. To confirm the quality of the immunohistochemistry, we
found positive cells for CTNB1 and BRAFV600E in respectively one
adamantinomatous craniopharingioma and one papillary
craniofaringioma (Figure 2).
Figure 2: A) Adamantinomatous craniopharingioma with typically
stratified epithelium and palisading arrangement of the basal cells.
Flat cells within a loose stroma are also evident (hematoxylin and
eosin [H&E] stain) B) β-catenin is localized to the cytoplasm and
the nucleus in an adamantinomatous craniopharyngioma. C)
Papillary craniopharingioma is formed of mature squamous
epithelium without surface maturation. Focal tissue dehiscence with
resultant pseudopapillary architecture is present (hematoxylin and
eosin [H&E] stain). D) positive staining for BRAFV600E was
characterized by diffuse and moderate cytoplasmic staining of the
tumor cells.
BRAFV600E and CTNNB1 (β-catenin) mutation analysis
We additionally performed sequencing in all cases. None of the
seven RCC, showed mutations in BRAF (Figure 1) and CTNNB1 (ß-
catenin).
Discussion
Rathke's cleft cysts and craniopharyngiomas typically arise in the
sellar region and on histological examination by some authors they are
considered part of a disease spectrum [2].
Histological evidence are shown by Park, et al. [4] which described
the occurrence of a primary tumor with microscopic features of RCC,
followed by a progression diagnosed as aCP with nuclear accumulation
of beta-catenin, arguing for the possibility that CPs may develop from
RCCs directly due to beta-catenin mutations.
Moreover other cases of RCC with smooth transitions from single
cuboidal epithelium to squamous and/or stratified epithelium in
Rathke’s epithelia and ciliated and goblet cell craniopharyngioma are
believed to provide evidence for this spectrum [5,8].
Moreover, in practice, purely cystic CPs is extremely difficult to
distinguish from RCCs during preoperative analysis and by
microscopical evaluation. Nevertheless, differentiating both entities is
important because the operative management and follow-up is
different. One major factor is the risk of persisting endocrine deficits
after extensive resection of CP masses that can be avoided in less
aggressive partial resection of the RCC wall.
The recent acquisition that adamantinomatous and papillary
craniopharyngiomas harbour distinct molecular alterations i.e., β-
catenin (CTNB1) [5] and BRAFv600 mutations [8] respectively
stimulate us to screen a series of seven cases of RCC for both
mutations using immunohistochemistry and DNA sequencing.
Moreover we re-evaluated clinical, radiological and histopathological
parameters.
Radiological re-evaluation in all seven cases demonstrated a
dumbbell-shaped cyst, with hypointense signal in T1-weighted images,
and hyperintense signal in T2-weighted images, relative to normal
brain parenchyma. The diameter of all cases was smaller than 20 mm.
Moreover in three of 7 Rathke cleft cysts and the intrasphenoidal lesion
MRI showed findings typical of a cystic lesion, causing a challenge in
differential diagnosis with CP.
The histological parameters of the cases showed columnar mucin-
producing, ciliated cells with a focal area of squamous epithelium. The
intrasphenoidal case showed columnar epithelial layer with cilia and
rare goblet cells: the peculiarity of the latter case was the unusual
location in the sphenoidal bone, which although rare, one case has
been reported [9].
All cases were negative for BRAFV600E and CTNB1 mutations. On
the other hand the two craniopharingioma adamantinomatous and
papillary tested showed respectively BRAFV600E and CTNB1
immunopositivity. Published series of RCC do not harbour the BRAF
V600E mutation [10] except for a recent paper by Schweizer, et al. [11]
in which they analysed for BRAF status 33 RCC, and found 3 cases
harbouring BRAFV600E mutation. The authors performed
immunohistochemistry in all cases and pyrosequencing in 8 out 33.
Pyrosequencing results of the VE1 positive cases clearly indicated the
presence of a BRAF V600E mutation whereas in one case a low level
mutation was observed.
The histological re-evaluation of the three positive cases showed
unusual morphological features for RCC and also clinical parameters
were unusual especially the adult ages of patients that were typically of
RCC. This re-evaluation prompt the authors to re-diagnosed the BRAF
positive case as papillary craniopharyngiomas. The paper by Schweizer,
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et al. focuses on the importance of a careful histological evaluation of
cystic sellar lesion for an accurate distinction between RCC with
squamous metaplasia and papillary craniopharyngioma.
Our study was carried out in a series similar to those of Schweizer,
et al. with respect to number of sequenced cases. However, the
histological and radiological re-evaluation of the two BRAFv600E
mutated RCC cases confirmed that they were misdiagnosed papillary
craniopharyngioma, being composed ofesions showed a collagenous
cyst wall layered by flat squamous epithelium mixed with columnar
cells with cilia and goblet cells. Moreover the clinical parameters were
consistent with this diagnosis such as the young age of the case to allow
us to exclude a craniopharyngioma rare in young. Also MRI showed
features consistent with the diagnosis of RCC such as a dumbell-
shaped cyst, with hypointense signal in T1 and hyperintense signal in
T2-weighted images.
In conclusion the issue of a possible spectrum between papillary
craniopharyngiomas and Rathke’s cleft cysts, as supposed by others,
was not supported in our study, both on histological and genetic level.
Finally, in extensively cystic CP, difficult to differentiate from RCC, the
pathological evaluation associated with molecular findings could
definitively define the diagnosis.
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